Glucagon-like Peptide 1 Receptor Agonists - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • Oct. 25, 2024
  • Oct. 21, 2022
  • Sept. 2020
  • Sept. 2018
  • Sept. 2016
  • June 2015
  • Oct. 2013
  • Dec. 2011
  • Feb. 2010
  • Jan. 2010
  • Aug. 2006
  • May 2006
  • Feb. 2006 (initially developed)